453:
63:
165:
22:
306:
of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of flanders.bio.
401:
368:
509:
358:
321:
products. The network also welcomes research institutes, universities and providers of capital, services and technologies to the life sciences community.
175:
189:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
490:
390:
514:
309:
The flanders.bio network brings together companies with activities in the life sciences – companies that are for example developing
298:
and represents and supports around 350 member companies. The key strategic objectives of flanders.bio are knowledge exchange and
524:
314:
379:
241:
127:
407:
213:
99:
415:
278:
260:
146:
49:
483:
220:
106:
84:
385:
227:
186:
113:
80:
35:
476:
209:
95:
182:
198:
343:(Managing Partner Bioqube Factory Fund) is Chairman of the flanders.bio Board of Directors, with
73:
336:
303:
8:
234:
120:
194:
452:
519:
464:
310:
190:
41:
294:, founded in 2004, is the networking organisation for the life sciences sector in
460:
503:
318:
438:
299:
335:, previously co-General Manager (with Pascal Engelen), was appointed COO.
348:
374:
62:
402:
Institute for the promotion of
Innovation by Science and Technology
295:
369:
European
Federation of Pharmaceutical Industries and Associations
181:
Please help to demonstrate the notability of the topic by citing
363:
432:
396:
459:
This article related to a non-profit organization is a
437:
overview of the flanders.bio members is available on
359:
Belgian
Society of Biochemistry and Molecular Biology
176:
notability guidelines for companies and organizations
87:. Unsourced material may be challenged and removed.
510:Medical and health organisations based in Belgium
347:(CEO and co-founder at ViroVet) is Vice-Chairman.
501:
484:
391:Flemish institute for technological research
331:. Following his appointment in early 2022,
50:Learn how and when to remove these messages
491:
477:
279:Learn how and when to remove this message
261:Learn how and when to remove this message
147:Learn how and when to remove this message
439:https://flanders.bio/en/member-directory
502:
447:
380:Flanders Institute for Biotechnology
158:
85:adding citations to reliable sources
56:
15:
408:Participatiemaatschappij Vlaanderen
13:
416:Science and technology in Flanders
14:
536:
515:Science and technology in Belgium
426:
31:This article has multiple issues.
451:
163:
61:
20:
72:needs additional citations for
39:or discuss these issues on the
317:or agricultural or industrial
1:
525:Non-profit organization stubs
421:
386:Flanders Investment and Trade
302:, human capital development,
463:. You can help Knowledge by
7:
352:
10:
541:
446:
183:reliable secondary sources
172:The topic of this article
174:may not meet Knowledge's
315:medical technologies
304:internationalization
81:improve this article
311:biopharmaceuticals
178:
472:
471:
289:
288:
281:
271:
270:
263:
245:
173:
157:
156:
149:
131:
54:
532:
493:
486:
479:
455:
448:
284:
277:
266:
259:
255:
252:
246:
244:
203:
167:
166:
159:
152:
145:
141:
138:
132:
130:
89:
65:
57:
46:
24:
23:
16:
540:
539:
535:
534:
533:
531:
530:
529:
500:
499:
498:
497:
444:
429:
424:
355:
285:
274:
273:
272:
267:
256:
250:
247:
204:
202:
180:
168:
164:
153:
142:
136:
133:
90:
88:
78:
66:
25:
21:
12:
11:
5:
538:
528:
527:
522:
517:
512:
496:
495:
488:
481:
473:
470:
469:
456:
442:
441:
435:
428:
427:External links
425:
423:
420:
419:
418:
413:
410:
405:
399:
394:
388:
383:
377:
372:
366:
361:
354:
351:
327:is the CEO of
325:Wouter Piepers
287:
286:
269:
268:
171:
169:
162:
155:
154:
69:
67:
60:
55:
29:
28:
26:
19:
9:
6:
4:
3:
2:
537:
526:
523:
521:
518:
516:
513:
511:
508:
507:
505:
494:
489:
487:
482:
480:
475:
474:
468:
466:
462:
457:
454:
450:
449:
445:
440:
436:
434:
431:
430:
417:
414:
411:
409:
406:
403:
400:
398:
395:
392:
389:
387:
384:
381:
378:
376:
373:
370:
367:
365:
362:
360:
357:
356:
350:
349:
346:
345:Erwin Blomsma
342:
338:
337:
334:
333:Willem Dhooge
330:
326:
322:
320:
316:
312:
307:
305:
301:
297:
293:
283:
280:
265:
262:
254:
243:
240:
236:
233:
229:
226:
222:
219:
215:
212: –
211:
210:"FlandersBio"
207:
206:Find sources:
200:
196:
192:
188:
184:
177:
170:
161:
160:
151:
148:
140:
129:
126:
122:
119:
115:
112:
108:
105:
101:
98: –
97:
96:"FlandersBio"
93:
92:Find sources:
86:
82:
76:
75:
70:This article
68:
64:
59:
58:
53:
51:
44:
43:
38:
37:
32:
27:
18:
17:
465:expanding it
458:
443:
433:flanders.bio
344:
340:
339:
332:
329:flanders.bio
328:
324:
323:
308:
300:valorisation
292:flanders.bio
291:
290:
275:
257:
248:
238:
231:
224:
217:
205:
143:
134:
124:
117:
110:
103:
91:
79:Please help
74:verification
71:
47:
40:
34:
33:Please help
30:
187:independent
504:Categories
422:References
251:March 2015
221:newspapers
195:redirected
137:March 2015
107:newspapers
36:improve it
412:Pharma.be
375:EuropaBio
341:Dirk Reyn
185:that are
42:talk page
520:Flanders
353:See also
296:Flanders
371:(EFPIA)
319:biotech
235:scholar
199:deleted
121:scholar
393:(VITO)
364:BIO.be
237:
230:
223:
216:
208:
191:merged
123:
116:
109:
102:
94:
404:(IWT)
382:(VIB)
242:JSTOR
228:books
197:, or
128:JSTOR
114:books
461:stub
397:GIMV
214:news
100:news
83:by
506::
313:,
193:,
45:.
492:e
485:t
478:v
467:.
282:)
276:(
264:)
258:(
253:)
249:(
239:·
232:·
225:·
218:·
201:.
179:.
150:)
144:(
139:)
135:(
125:·
118:·
111:·
104:·
77:.
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
